X4 Pharmaceuticals, Inc.
XFOR
$3.30
$0.123.77%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -62.70% | 7.52% | -10.64% | -4.73% | 19.42% |
| Total Receivables | 118.38% | 67.24% | 204.27% | 173.03% | 4.15% |
| Inventory | 281.47% | -- | -- | -- | -- |
| Prepaid Expenses | -0.42% | -22.20% | -20.72% | -19.28% | -5.56% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -58.42% | 9.58% | -8.11% | -3.31% | 18.81% |
|
|
|||||
| Total Current Assets | -58.42% | 9.58% | -8.11% | -3.31% | 18.81% |
| Net Property, Plant & Equipment | -48.94% | -31.09% | -24.30% | -22.49% | -22.40% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -7.23% | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 31.36% | 101.94% | 44.85% | 89.95% | 65.80% |
| Total Assets | -50.07% | 15.89% | -0.55% | 2.81% | 21.46% |
|
|
|||||
| Total Accounts Payable | -3.47% | 24.40% | -3.64% | 5.47% | 56.34% |
| Total Accrued Expenses | -33.83% | -6.40% | 79.50% | 20.24% | 30.19% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 16.72% | 15.00% | 13.83% | 9.50% | -38.70% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -20.78% | 9.95% | 43.81% | 15.04% | 29.89% |
|
|
|||||
| Total Current Liabilities | -20.78% | 9.95% | 43.81% | 15.04% | 29.89% |
| Long-Term Debt | 1.08% | 37.95% | 38.22% | 38.48% | 135.68% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -59.77% | -52.16% | -46.02% | -38.31% | -35.15% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -83.88% | -85.40% | -9.49% | -46.72% | -79.03% |
| Total Liabilities | -12.88% | -3.67% | 29.26% | 12.15% | 9.73% |
|
|
|||||
| Common Stock & APIC | 2.15% | 1.37% | 1.61% | 1.67% | 1.78% |
| Retained Earnings | -23.24% | 2.76% | -7.84% | -3.65% | 3.86% |
| Treasury Stock & Other | 13.21% | 17.42% | -2.52% | 4.20% | -33.61% |
| Total Common Equity | -95.80% | 2,114.67% | -56.65% | -11.80% | 39.85% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -95.80% | 2,114.67% | -56.65% | -11.80% | 39.85% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -95.80% | 2,114.67% | -56.65% | -11.80% | 39.85% |
|
|
|||||